MBMargaret M. Byrne

Margaret M. Byrne

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Margaret M. Byrne has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Caregiver Burden and Neuro‐Oncology Patient Function: Impacts on Relationship Quality

    by Maija Reblin, Deanna Witte, Kristen J. Wells, Peter Forsyth, Margaret M. Byrne

    Background: Prior work has identified the protective effects of relationship quality on cancer outcomes. However, less work has focused on how the cancer experience can change relationship quality. Aims: To describe neuro‐oncology patient‐caregiver relationship quality over time and identify the impact of caregiver burden and patient physical and cognitive function on perceptions of relationship quality. Methods: This is a secondary analysis of data obtained at enrollment and 8 weeks. Actor‐partner interdependence models of patient and caregiver ratings of their relationship to each other (Couples Satisfaction Index) over time also included baseline measures of patient cognitive and physical function (Neuro‐QOL), caregiver burden (Zarit), and change in these measures. Results: Data from 124 neuro‐oncology patient‐caregiver dyads were analyzed. Relationship quality at both time points, on average, indicated non‐distressed relationships, but patients rated relationship quality significantly better than caregivers. Both rated relationship quality significantly worse over time ( p values < 0.022). At baseline, caregiver burden was significantly negatively associated with patient ( p = 0.014) and caregiver relationship quality ( p < 0.001). Patient and caregiver baseline relationship quality predicted their own 8‐week scores (actor effect; p values < 0.001). Baseline patient cognitive function ( p = 0.011) and change in patient cognitive function ( p = 0.039) were positively associated with 8‐week patient relationship quality. Change in caregiver burden was negatively associated with 8‐week caregiver relationship quality ( p < 0.001). Conclusions: Prior research has largely focused on relationship quality as a resource, but factors associated with the cancer experience may impact perceptions of relationship quality. Lowering caregiver burden may be beneficial to preserving this important coping resource.

  • Open Access

    Implementing Sustainable Mobile Health Technology to Optimize a Smoking Cessation Program for Lao People With HIV (Project I-STOP): Protocol for a Hybrid Type-2 Pragmatic Effectiveness-Implementation Study

    by Phonepadith Xangsayarath, Cate Moriasi, Phayvanh Keopaseuth, Khatthanaphone Phandouangsy, Khanti Thongkham, Bouathong Simanovong, Michael S Businelle, Steven K Sutton, Margaret M Byrne, Kea L Turner, et al.

    Background: Tobacco use remains the leading modifiable risk factor for causing cancer worldwide, particularly among people with HIV. In Laos, 61%‐80% of male people with HIV and 3%‐10% of female people with HIV smoke cigarettes. They currently have no theoretically and empirically based smoking cessation support. Our team developed a scalable and affordable mHealth (mobile health)–based automated treatment program to support Lao and Cambodian smokers to quit smoking. We also pioneered the Ask-Advise-Connect approach to identify patients who smoke and to connect them to treatment. Objective: This hybrid type-2 pragmatic effectiveness-implementation study aims to compare 2 smoking cessation implementation strategies in 8 antiretroviral therapy (ART) clinics in the 6 most populous regions across Laos, using a parallel cluster randomized trial design. Methods: We will compare an Ask-Advice-Connect approach paired with an mHealth-based automated treatment program (AA-MAP) with an Ask-Advice-Connect approach paired with less resource-intensive printed self-help material (AA-SH). To guide assessment of implementation determinants and outcomes, we use the Practical, Robust Implementation and Sustainability Model framework. Aim 1 is to evaluate the reach and effectiveness of AA-MAP vs AA-SH. Reach is the proportion of people with HIV who smoke and are willing to make a quit attempt that enroll in treatment. Effectiveness is the proportion of enrolled participants (n=up to 1200) who achieve biochemically confirmed point prevalence abstinence 6 months after enrollment. We hypothesize that compared with AA-SH, AA-MAP will have a lower reach but will be more effective. We will also estimate the real-world impact (impact = reach × effectiveness) of each intervention. Aim 2 is to evaluate other implementation outcomes (eg, adoption, implementation fidelity, and sustainability) and identify implementation determinants of AA-MAP and AA-SH in the ART clinic setting using mixed methods. Aim 3 is to conduct a comprehensive assessment of the resource use and costs of implementing AA-MAP and AA-SH and calculate the absolute and relative cost-effectiveness of the 2 intervention strategies. Results: The study has been funded since August 2024. This study was approved by the ethical review boards of the Lao Ministry of Health–National Ethics Committee for Health Research and the University of Oklahoma Health Campus. The Multiple Principal Investigators met with the selected ART clinics. As of September 2026, we have launched the implementation of AA-SH and AA-MAP at 4 ART clinics. We plan to expand the implementation at the other ART clinics by December 2026. Conclusions: This project will contribute important actionable inputs that will inform the influential Lao National Tobacco Control Committee and Ministry of Health to implement the strategies in diverse hospital settings in future large-scale hybrid type II/III trials. Ultimately, our course of research can transform health care delivery and contribute to reducing tobacco-related morbidities and mortalities in Laos.

  • Change in caregiver emotional ratings in response to neuro-oncology caregiver navigation sessions

    by Maija Reblin, Steven K Sutton, Kristen J Wells, Deanna Witte, Peter Forsyth, Margaret M Byrne

    Background: The CARING intervention is designed to help neuro-oncology caregivers recognize existing social support and improve coping. Caregivers received 8 weekly phone-based individual manualized sessions with a navigator. Our objective was to understand the impact of CARING navigation sessions on ratings of stress, frustration, in control, and hopefulness for each session and across the sessions. Methods: In this secondary analysis of data from a randomized controlled trial of CARING, caregiver self-report emotional ratings before and after each of 8 navigator sessions were analyzed. Navigators asked caregivers to rate their level of stress, frustration, feeling in control, and feeling hopeful. Responses were documented in the navigation log. Paired t-tests were conducted on each emotional construct for each session. Generalized estimating equations (GEEs) analyzed within- and between-session change for each emotional construct. Results: Seventy-three caregivers provided at least 1 emotional rating in a navigation session. There were significant improvements from pre- to post- for all sessions for both stress and frustration ratings (ts < −3.06, Ps < .004). The majority of sessions also had significant improvements for feeling hopeful and in control (5 of 8 sessions; all ts > 2.66, Ps <.02). Generalized estimating equation results mirror t-test findings for within-session ratings and show a significant decrease for feeling in control across sessions (b = −0.08, P = .035). Conclusions: Our findings suggest emotional improvement for each navigation session, with more consistent change in negative than in positive ratings. Navigation may offer emotional regulation and coping tools for neuro-oncology caregivers.

  • Open Access

    A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers

    by Steven K. Sutton, Kea Turner, Katherine Chung-Bridges, Susan T. Vadaparampil, Rania Abdulla, Mariana D. Arevalo, Natasha Avrilien, Margaret M. Byrne, Edelise Endemano, Jennifer Garcia Hernandez, et al.

    BackgroundSkin cancers are the most common type of cancer in the United States, occur in all segments of the population, and are preventable. Our previous research with primary care patients’ demonstrated interest in and efficacy of a precision prevention intervention providing feedback on MC1R risk level (higher versus average) in combination with prevention education materials relative to a standard educational intervention. Our current study is a Hybrid type 1 effectiveness-implementation trial deployed at six federally-qualified health centers. This paper presents the study protocol.MethodsA community advisory panel will guide development of study materials and measures. Staff training at each clinic will be completed in-person. Patients will be approached and screened in-person. Those completing genetic testing and the baseline survey will be randomized to the precision versus standard intervention for each risk level with a target sample size of 286 for each risk level by condition. The two primary effectiveness outcomes are a tanning score (5 items assessing intentional and unintentional tanning) and number of sunburns with assessments at 6 and 12 months. Effectiveness comparisons will focus on the precision relative to the standard intervention among higher risk participants. Implementation data will be collected to identify barriers and facilitators.ResultsThe study is ongoing (Year 2 of 5) with study materials, intervention materials, and clinic staff training completed. Effectiveness and implementation outcomes will be evaluated following study completion.ConclusionsResults will guide subsequent scale-up of the precision intervention, including modifications of the intervention as well as methods for implementation.

  • The CARING intervention for neuro-oncology family caregivers: Primary outcomes from an abbreviated randomized controlled trial

    by Maija Reblin, Steven K Sutton, Hyojin Choi, Deanna Witte, Kristen J Wells, Bradley J Zebrack, Peter Forsyth, Margaret M Byrne

    Background: We developed CARING to support neuro-oncology caregivers. CARING includes eSNAP, a web-based tool to identify social support resources, and 8 weeks of individual phone-based non-clinical navigation focused on support identification and coping skills. This study aimed to evaluate the efficacy of CARING on caregiver and patient psychosocial outcomes. Methods: We compared CARING to a waitlist control (WLC) in an RCT. Neuro-oncology patients and their caregivers were recruited from a National Cancer Institute (NCI)-designated comprehensive cancer center in Florida from February 2020 to June 2024. Eighty-one caregivers were assigned to CARING and 35 to WLC. All participants completed baseline measures, including demographics and health data. Primary outcomes collected at 8 weeks were caregiver support and self-efficacy. Secondary outcomes were caregiver burden, personal gain, and caregiver and patient anxiety and depressive symptoms. General Linear Mixed Models examined changes in outcomes from baseline to 8 weeks by condition. Results: No significant demographic differences existed between conditions. CARING caregivers reported significantly lower ratings of stress/frustration compared to feeling in control/hope (F(1,92) = 6.19, P = .015) at 8 weeks compared to WLC. There was a significant increase in personal gain (M = 0.7, SD = 2.5, t(63) = 2.13, P = .037) and a marginally-significant increase in self-efficacy (M = 1.6, SD = 6.6, t(61) = 1.88, P = .065) for CARING caregivers at 8 weeks. Although the intervention is targeted only at caregivers, patients of CARING caregivers reported marginally significantly fewer depressive symptoms (F(1,51) = 2.89, P = .096) at 8 weeks compared to WLC. Conclusion: CARING decreases the ratio of negative to positive emotions and perceptions of personal gain in caregivers at 8 weeks, compared to WLC.


  • The CARING intervention for neuro-oncology family caregivers: Randomized controlled trial feasibility, eSNAP/caregiver navigation engagement, and acceptability

    by Hyojin Choi, Steven K Sutton, Deanna Witte, Nina Pastore, Kristen J Wells, Bradley J Zebrack, Peter Forsyth, Margaret M Byrne, Maija Reblin

    Background: To address the unmet support needs of neuro-oncology family caregivers, our team developed an 8-week intervention, CARING. CARING consists of electronic Social Network Assessment Program (eSNAP), a web-based tool to identify and organize support resources, and manualized navigation sessions for caregivers. Our objective is to evaluate the methodological feasibility of our randomized controlled trial (RCT) study design, and caregiver engagement and acceptability of CARING. Methods: The RCT compared CARING to a waitlist control. RCT feasibility was evaluated based on caregiver and patient recruitment and retention. CARING intervention engagement was evaluated via caregiver participation data over 8 weeks. CARING intervention acceptability was evaluated via quantitative satisfaction scales, as well as qualitative debrief interviews of caregiver participants at 8 weeks. Results: Of 502 potentially eligible patient–caregiver dyads approached, 148 consented (29%). Although effective, randomization was ended due to mid-study coronavirus disease (COVID)-related administrative issues that impacted recruitment rates. In the last year, all participants were assigned to the intervention condition to prioritize the evaluation of CARING. Of those enrolled, 87% of caregivers and 77% of patients completed the Week-8 assessment. Of the 81 caregivers assigned to CARING, 88% used eSNAP at least once, and 73% engaged with 6+ navigation topics. At 8 weeks, 77% of caregivers reported that they liked CARING and 81% found it helpful. Qualitative data provided additional insights into intervention acceptability. Conclusions: Results suggest that the RCT methodology used is feasible, and neuro-oncology caregivers engaged with CARING components and found the intervention acceptable. Future studies can apply key lessons in developing or implementing other caregiver interventions.


  • Open Access

    Easy ensemble classifier-group and intersectional fairness and threshold (EEC-GIFT): a fairness-aware machine learning framework for lung cancer screening eligibility using real-world data

    by Piyawan Conahan, Lary A Robinson, Trung Le, Gilmer Valdes, Matthew B Schabath, Margaret M Byrne, Lee Green, Issam El Naqa, Yi Luo

    Background: We use real-world data to develop a lung cancer screening (LCS) eligibility mechanism that is both accurate and free from racial bias. Methods: Our data came from the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial. We built a systematic fairness-aware machine learning framework by integrating a Group and Intersectional Fairness and Threshold (GIFT) strategy with an easy ensemble classifier—(EEC-) or logistic regression—(LR-) based model. The best LCS eligibility mechanism EEC-GIFT* and LR-GIFT* were applied to the testing dataset and their performances were compared to the 2021 US Preventive Services Task Force (USPSTF) criteria and PLCOM2012 model. The equal opportunity difference (EOD) of developing lung cancer between Black and White smokers was used to evaluate mechanism fairness. Results: The fairness of LR-GIFT* or EEC-GIFT* during training was notably greater than that of the LR or EEC models without greatly reducing their accuracy. During testing, the EEC-GIFT* (85.16% vs 78.08%, P < .001) and LR-GIFT* (85.98% vs 78.08%, P < .001) models significantly improved sensitivity without sacrificing specificity compared to the 2021 USPSTF criteria. The EEC-GIFT* (0.785 vs 0.788, P = .28) and LR-GIFT* (0.785 vs 0.788, P = .30) showed similar area under receiver operating characteristic curve values compared to the PLCOM2012 model. While the average EODs between Blacks and Whites were significant for the 2021 USPSTF criteria (0.0673, P < .001), PLCOM2012 (0.0566, P < .001), and LR-GIFT* (0.0081, P < .001), the EEC-GIFT* model was unbiased (0.0034, P = .07). Conclusion: Our EEC-GIFT* LCS eligibility mechanism can significantly mitigate racial biases in eligibility determination without compromising its predictive performance.


  • Addressing a critical need for caregiver support in neuro-oncology: development of a caregiver navigation intervention using eSNAP social resource visualization

    by Maija Reblin, Kristen J. Wells, Amy Otto, Rachael McCormick, Laura Rodriguez, Kerie Walters, Steven K. Sutton, Bradley Zebrack, Peter Forsyth, Margaret M. Byrne

    Informal caregivers are key to oncology care, but often have unmet needs, leading to poor psychological and physical health outcomes. Comprehensive, proactive caregiver support programs are needed. We describe the development of a support intervention for caregivers of persons with brain tumors. The intervention uses a caregiver navigator to help participants identify and capitalize on existing social support resources captured using a web-based tool (eSNAP) and connects participants to existing formal services. We describe the iterative development process of the manualized intervention with particular focus on the caregiver navigator sessions. The process included review of the literature and published patient navigation programs, expert and stakeholder review, and study team member review. Quantitative and qualitative data were captured from the first 15 participants randomized to receive the intervention, enrolled from February 2020 to December 2020. Four participants dropped from the study, 9 completed at least 7 modules, and 8 participants completed all 8. Quantitative and qualitative data were collected primarily from those who completed the intervention; data suggest caregivers were satisfied with the intervention and found it helpful. Our intervention is one of the first theory-based caregiver support interventions to include caregiver navigation in neuro-oncology. We use best-practice guidelines for design, including extensive stakeholder feedback. COVID-19 may have impacted recruitment and participation, but some preliminary data suggest that those able to engage with the intervention find it helpful. Data collection is ongoing in a larger trial. If effective, caregiver navigation could be a model for future interventions to ensure caregiver support.


  • Self‐help smoking cessation intervention for Spanish‐speaking Hispanics/Latinxs in the United States: A randomized controlled trial

    by Vani N. Simmons, Steven K. Sutton, Patricia Medina‐Ramirez, Ursula Martinez, Karen O. Brandon, Margaret M. Byrne, Cathy D. Meade, Lauren R. Meltzer, Thomas H. Brandon

    Background: Hispanic/Latinx smokers living in the United States face unique challenges in quitting smoking. This study evaluated the efficacy of a culturally relevant, Spanish‐language, extended self‐help smoking cessation intervention among Hispanic smokers.Methods: A 2‐arm parallel randomized controlled trial was conducted with Hispanic/Latinx smokers living in the United States who preferred health information in Spanish and smoked 5 or more cigarettes per week. Participants were randomly allocated to receive Libre del Cigarrillo (LDC), which consisted of 11 booklets and 9 pamphlets mailed monthly over 18 months, or the usual care (UC), which was a single Spanish‐language self‐help booklet from the National Cancer Institute. The primary outcome was self‐reported 7‐day point prevalence smoking abstinence assessed 6, 12, 18, and 24 months after the baseline. Eight prespecified moderators of the intervention were evaluated. Cost‐effectiveness was also evaluated. All statistical tests were 2‐sided.Results: Data from all participants randomized to LDC (n = 714) or UC (n = 703) were used for analyses after multiple imputation to manage missing data. Generalized estimating equation analyses indicated that LDC abstinence rates were higher (P < .001) across all assessments. Logistic regression analyses revealed that at 24 months, the abstinence rate was greater for LDC (33.1%) than UC (24.3%; odds ratio, 1.54; 95% confidence interval, 1.18‐2.02; P = .002). Men exhibited a strong intervention effect at all assessments (P values < .001), whereas the intervention effect for women was observed only at 6 and 12 months (P values < .018). In comparison with UC, the incremental cost per quitter in the LDC arm was $648.43 at 18 months and $683.93 at 24 months.Conclusions: A culturally relevant, Spanish‐language intervention was efficacious and cost‐effective for smoking cessation.Lay Summary: Research is needed to develop interventions for ethnic minority smokers. The aim of the current study was to test a Spanish‐language adaptation of a validated and easily implemented self‐help smoking cessation intervention in a nationwide randomized controlled trial. The findings demonstrated that the intervention produced greater smoking abstinence in comparison with a standard self‐help booklet. Participants also were more satisfied with the intervention, and it was cost‐effective. Efforts aimed at promoting tobacco abstinence in this underserved population could have significant public health implications, including potential reductions in cancer health disparities associated with tobacco smoking.